National Institute for Health and Care Research logo
National Institute for Health and Care Research

Reducing central line-associated bloodstream infections in neonates

Funds a UK trial comparing interventions to cut bloodstream infections from neonatal lines.

NIHR's Health Technology Assessment Programme runs this as a two-stage commissioned call: an outline application is assessed first, and only shortlisted applicants are invited to submit a full application, which the HTA funding committee then decides on. This is a focused opportunity -- NIHR intends to fund a single study from the whole call, not a portfolio of related projects. The outline stage

The HTA Programme wants a commissioned trial comparing ways to cut the rate of catheter-related bloodstream infections in newborns fitted with a central line, including PICC lines. Applicants define and justify their own intervention, comparator against standard local care, and outcome measures able to distinguish a true infection from sample contamination. The programme is especially interested in addressing wide variation in current infection-prevention bundles across neonatal units.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.18 Nov 2026
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides →
European Commission logo
Scheduled

Clinical trials for advancing innovative interventions for neurodegenerative diseases

🇪🇺European Commission · European Union

Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.

MedtechBiotech
€10MApr'27
European Commission logo
Scheduled

Personalised approaches to reduce risks from adverse drug reactions due to multiple medications

🇪🇺European Commission · European Union

Funds safer medication management using biomarkers, clinical data and decision support.

MedtechBiotech+1
€8M – €10MApr'27
Innovate UK logo
Open

National Materials Innovation Programme: CR&D Rd1

🇬🇧Innovate UK · United Kingdom

Funds UK-registered businesses collaborating on industrial research into advanced materials, covering up to 70% of project costs from a £12 million pool.

Advanced MaterialsMedtech+1
£500K – £1MOct'26
Department for Science, Innovation and Technology logo
Open

Life Sciences Transformational R&D Investment Fund (TRIF) Pilot

🇬🇧DSIT · United Kingdom

Capital grants for large-scale UK life sciences R&D investments.

BiotechMedtech+1
£5M – £25MApr'28
European Commission logo
Scheduled

Independent Living and Inclusion for Persons with Disabilities

🇪🇺European Commission · European Union

Funds person-centred health, care and technology that help people with disabilities live independently and belong in their communities.

MedtechBiotech
€6M – €8MApr'27
European Commission logo
Scheduled

Cancer Mission: Functional Genomics for New Treatments

🇪🇺European Commission · European Union

Funds €7–8M projects that use functional genomics and patient data to uncover precise new targets for difficult-to-treat cancers.

BiotechMedtech+2
€7M – €8MSep'27